Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.
2.

A promoter polymorphism of the CYP27B1 gene is associated with Addison's disease, Hashimoto's thyroiditis, Graves' disease and type 1 diabetes mellitus in Germans.

Lopez ER, Zwermann O, Segni M, Meyer G, Reincke M, Seissler J, Herwig J, Usadel KH, Badenhoop K.

Eur J Endocrinol. 2004 Aug;151(2):193-7.

3.

Programmed death ligand 1 (PD-L1) gene variants contribute to autoimmune Addison's disease and Graves' disease susceptibility.

Mitchell AL, Cordell HJ, Soemedi R, Owen K, Skinningsrud B, Wolff AB, Ericksen M, Undlien D, Husebye E, Pearce SH.

J Clin Endocrinol Metab. 2009 Dec;94(12):5139-45. doi: 10.1210/jc.2009-1404. Epub 2009 Oct 22.

PMID:
19850680
4.

Genetic association studies of the FOXP3 gene in Graves' disease and autoimmune Addison's disease in the United Kingdom population.

Owen CJ, Eden JA, Jennings CE, Wilson V, Cheetham TD, Pearce SH.

J Mol Endocrinol. 2006 Aug;37(1):97-104.

PMID:
16901927
5.

Association of the CYP27B1 C(-1260)A polymorphism with autoimmune Addison's disease.

Fichna M, Zurawek M, Januszkiewicz-Lewandowska D, Gryczyñska M, Fichna P, Sowiñski J, Nowak J.

Exp Clin Endocrinol Diabetes. 2010 Aug;118(8):544-9. doi: 10.1055/s-0029-1241206. Epub 2009 Dec 8.

PMID:
19998245
6.

The rs1990760 polymorphism within the IFIH1 locus is not associated with Graves' disease, Hashimoto's thyroiditis and Addison's disease.

Penna-Martinez M, Ramos-Lopez E, Robbers I, Kahles H, Hahner S, Willenberg H, Reisch N, Seidl C, Segni M, Badenhoop K.

BMC Med Genet. 2009 Dec 4;10:126. doi: 10.1186/1471-2350-10-126.

7.

Association of autoimmune Addison's disease with alleles of STAT4 and GATA3 in European cohorts.

Mitchell AL, Macarthur KD, Gan EH, Baggott LE, Wolff AS, Skinningsrud B, Platt H, Short A, Lobell A, Kämpe O, Bensing S, Betterle C, Kasperlik-Zaluska A, Zurawek M, Fichna M, Kockum I, Nordling Eriksson G, Ekwall O, Wahlberg J, Dahlqvist P, Hulting AL, Penna-Martinez M, Meyer G, Kahles H, Badenhoop K, Hahner S, Quinkler M, Falorni A, Phipps-Green A, Merriman TR, Ollier W, Cordell HJ, Undlien D, Czarnocka B, Husebye E, Pearce SH.

PLoS One. 2014 Mar 10;9(3):e88991. doi: 10.1371/journal.pone.0088991. eCollection 2014. Erratum in: PLoS One. 2014;9(7):e102428.

8.

Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility.

Sutherland A, Davies J, Owen CJ, Vaikkakara S, Walker C, Cheetham TD, James RA, Perros P, Donaldson PT, Cordell HJ, Quinton R, Pearce SH.

J Clin Endocrinol Metab. 2007 Aug;92(8):3338-41. Epub 2007 May 29.

PMID:
17535987
9.

A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients.

Kemp EH, Ajjan RA, Husebye ES, Peterson P, Uibo R, Imrie H, Pearce SH, Watson PF, Weetman AP.

Clin Endocrinol (Oxf). 1998 Nov;49(5):609-13.

PMID:
10197076
10.

No association of the codon 55 methionine to valine polymorphism in the SUMO4 gene with Graves' disease.

Jennings CE, Owen CJ, Wilson V, Pearce SH.

Clin Endocrinol (Oxf). 2005 Mar;62(3):362-5.

PMID:
15730420
11.

Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency.

Skinningsrud B, Husebye ES, Pearce SH, McDonald DO, Brandal K, Wolff AB, Løvås K, Egeland T, Undlien DE.

J Clin Endocrinol Metab. 2008 Sep;93(9):3310-7. doi: 10.1210/jc.2008-0821. Epub 2008 Jul 1.

PMID:
18593762
12.

The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease.

Velaga MR, Wilson V, Jennings CE, Owen CJ, Herington S, Donaldson PT, Ball SG, James RA, Quinton R, Perros P, Pearce SH.

J Clin Endocrinol Metab. 2004 Nov;89(11):5862-5.

PMID:
15531553
13.

Screening for an AIRE-1 mutation in patients with Addison's disease, type 1 diabetes, Graves' disease and Hashimoto's thyroiditis as well as in APECED syndrome.

Meyer G, Donner H, Herwig J, Böhles H, Usadel KH, Badenhoop K.

Clin Endocrinol (Oxf). 2001 Mar;54(3):335-8.

PMID:
11298085
14.

Association of the large multifunctional proteasome (LMP2) gene with Graves' disease is a result of linkage disequilibrium with the HLA haplotype DRB1*0304-DQB1*02-DQA1*0501.

Heward JM, Allahabadia A, Sheppard MC, Barnett AH, Franklyn JA, Gough SC.

Clin Endocrinol (Oxf). 1999 Jul;51(1):115-8.

PMID:
10468973
15.

[Relevance of CYP27B1 gene promoter polymorphism to autoimmune thyroid diseases].

Yang J, Xiong F.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 Apr;28(4):606-8. Chinese.

16.

Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease.

Blomhoff A, Lie BA, Myhre AG, Kemp EH, Weetman AP, Akselsen HE, Huseby ES, Undlien DE.

J Clin Endocrinol Metab. 2004 Jul;89(7):3474-6.

PMID:
15240634
17.

Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's disease.

Baker PR, Baschal EE, Fain PR, Triolo TM, Nanduri P, Siebert JC, Armstrong TK, Babu SR, Rewers MJ, Gottlieb PA, Barker JM, Eisenbarth GS.

J Clin Endocrinol Metab. 2010 Oct;95(10):E263-70. doi: 10.1210/jc.2010-0508. Epub 2010 Jul 14.

18.

Analysis of extended human leukocyte antigen haplotype association with Addison's disease in three populations.

Gombos Z, Hermann R, Kiviniemi M, Nejentsev S, Reimand K, Fadeyev V, Peterson P, Uibo R, Ilonen J.

Eur J Endocrinol. 2007 Dec;157(6):757-61.

19.

CYP21A2 polymorphisms in patients with autoimmune Addison's disease, and linkage disequilibrium to HLA risk alleles.

Brønstad I, Skinningsrud B, Bratland E, Løvås K, Undlien D, Sverre Husebye E, Wolff AS.

Eur J Endocrinol. 2014 Dec;171(6):743-50. doi: 10.1530/EJE-14-0432. Epub 2014 Sep 23.

20.

Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease.

Gambelunghe G, Falorni A, Ghaderi M, Laureti S, Tortoioli C, Santeusanio F, Brunetti P, Sanjeevi CB.

J Clin Endocrinol Metab. 1999 Oct;84(10):3701-7.

PMID:
10523017

Supplemental Content

Support Center